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Acupuncture is increasingly offered as a treatment option for managing cancer-related
symptoms. In addition to randomized controlled trials, patient-reported outcomes may
be needed to establish treatment effectiveness. This study retrospectively examined
the symptoms and the satisfaction ratings of 90 patients receiving acupuncture at an inte-
grative oncology clinic. At least two acupuncture sessions were completed by 72% of the
sample. The prevalence rates of fatigue, pain, anxiety, physical distress, emotional
distress, and poor quality of life before acupuncture were > 62%. Paired t tests revealed
a significant reduction in symptoms from baseline until after the first acupuncture session
and after the last session (p < 0.05). Fewer (21%) patients reported nausea, which was
significantly reduced after the first session, but not the last session. Reductions repre-
sented clinically meaningful differences in 33e41% of patients after the first session
and in 41e53% of patients after the last session for all symptoms, except nausea. A small
subset of patients (0e8%) reported worsening symptoms after acupuncture. The majority
were satisfied with the service. The results of this study suggest that acupuncture may be
useful as an adjunct treatment for cancer symptom management. While high-quality tri-
als are still needed to establish the treatment’s efficacy, patients may benefit from these
primarily safe, low-cost services.tt Cancer Center and Research Institute, 12902 Magnolia Drive, MRC-SCM, Tampa, FL 33612, USA.
(L.M.A. Thompson).
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acopuncture Institute.
128 L.M.A. Thompson et al.1. Introduction
Acupuncture has been used for thousands of years in
Eastern medicine, although Western medicine has only
recently recognized acupuncture as an acceptable treat-
ment modality for managing physical symptoms and ill-
nesses [1]. In 1996, the United States Food and Drug
Administration approved acupuncture needles as medical
devices [2], which legitimized acupuncture as a health
practice. The National Institute of Health Office of Alter-
native Medicine was created in 1991, which spurred
research into unconventional practices such as acupuncture
[3]. (In 1998, this office was transformed into the National
Center for Complementary and Alternative Medicine; in
December 2014, the center was renamed the National
Center for Complementary and Integrative Health [3].)
Emerging evidence suggests that acupuncture may reduce
pain [4,5], chemotherapy-related nausea and vomiting [6],
hot flashes [7e9], fatigue [10], xerostomia [11,12], and
other symptoms [13,14] experienced by cancer patients.
The positive impact of acupuncture on mood and sleep has
also been documented [15].
Gaps exist in the research literature, particularly in
relation to understanding the mechanisms of action [16]
and designing adequate randomized controlled trials
(RCTs) [5] to demonstrate the effectiveness of acupunc-
ture; however, it has been established that acupuncture
performed by a qualified provider is safe. Studies of large
samples of individuals receiving acupuncture have identi-
fied low rates of serious or minor adverse events [17e19].
Within the oncology setting, evidence-based clinical prac-
tice guidelines have been published, and these guidelines
recommend that acupuncture be avoided in patients with
severe bleeding tendencies (e.g., neutropenia, thrombo-
cytopenia) and that needles should not be directly inserted
into tumor sites or areas of lymphedema [20].
Because of the established safety and potential benefits
of acupuncture, several integrative oncology programs in
the United States and Europe now offer this service to their
patients [21,22]. A review of studies published in English
that examined the use of complementary and alternative
medicine by cancer patients suggests that the rate of
acupuncture use is between 0.2% and 17% [23]. Because
cancer patients are already receiving acupuncture services,
it is important to document the patients’ response to these
treatments. Randomized controlled trials are the gold
standard for establishing the effectiveness of acupuncture;
however, patient-reported outcomes may also be needed
to understand whether patients perceive acupuncture to be
effective [24]. In recent observational studies, cancer pa-
tients have reported improvements in symptoms such as
pain, nausea, anxiety, and well-being after receiving
acupuncture [25,26]. An acupuncture service was estab-
lished in 2005 at the Moffitt Cancer Center (Tampa, FL,
USA), which is a National Cancer Institute-designated
comprehensive cancer center in southeast United States
and serves > 50,000 patients per year with nearly 340,000
outpatient visits. Acupuncture was provided by a physician
on a fee-for-service basis. Oncologists could refer patients
to the service for pain and symptom management or pa-
tients could self-refer. Self-referred patients requiredapproval from their oncologist before receiving the service.
As part of clinical care, patients provided information on
their symptoms and satisfaction with acupuncture services.
The purpose of this retrospective study was to obtain pre-
liminary patient-reported data on the impact of acupunc-
ture on symptom management in cancer.
2. Materials and methods
2.1. Study design
This was a retrospective review of acupuncture data
collected by a physician acupuncturist as part of clinical
care delivered between September 2010 and October 2012.
The study was approved by the University of South Florida
Institutional Review Board (Tampa, FL, USA).
2.2. Records
A total of 153 adults received 558 acupuncture treatments
from a physicianeacupuncture provider. Data collected as
part of clinical care was de-identified for research pur-
poses. Records with no symptom data (N Z 9) and records
for noncancer patients (i.e., cancer caregivers or cancer
center employees; N Z 54) were excluded. After applying
the exclusion criteria, 90 cancer patients remained who
had at least one acupuncture visit. Available demographic
data included sex, race, ethnicity, age, and cancer diag-
nosis. Data are presented for the first visit and final visit, if
available.
2.3. Measure
Before (i.e., baseline) and after (i.e., post) each
acupuncture treatment, patients completed clinical symp-
tom rating scales that assessed individual symptoms of
pain, nausea, fatigue and anxiety and overall physical
distress, overall emotional distress, and quality of life on a
10-point numerical rating scale from 1 (“no problem”) to 10
(“as bad as it can be”). The rating scales were designed for
clinical use and assessed only a limited number of symp-
toms to minimize patient response burden. The post-
acupuncture rating scale also included three satisfaction
items (rated on a 5-point numerical rating scale) that
measured the patient’s satisfaction with the session,
satisfaction with the provider, and likelihood of recom-
mending the service to others. Higher ratings represented
more satisfaction and greater likelihood of
recommendation.
2.4. Acupuncture treatment
Western medical acupuncture treatment was offered by
one internal medicine physician provider who trained in
acupuncture at a Western medical school. The provider had
been practicing acupuncture for approximately 6 years.
The service was provided in consultation rooms located in
the cancer center. Patients could be referred by their
oncologist or could be self-referred. For self-referred pa-
tients, the acupuncture physician obtained approval from
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Figure 1 Screening protocol and the number of completed
acupuncture visits.
Acupuncture for Symptom Control in Cancer 129the patient’s oncologist before initiating treatment. The
provider used manual acupuncture or electroacupuncture.
The surface of the skin was cleaned with an alcohol prep
pad before needle insertion. The needles used were Seirin
J-Type stainless steel filoform needles of various gauges
(Seirin-America, Weymouth, MA, USA). The treatment
regimen varied and clinical judgment was used by the
provider to select the appropriate points and the frequency
of treatment for each patient.
2.5. Statistical analysis
Data were analyzed using the 2002e2003 SAS Version 9.1
software (SAS Institute Inc., Cary, NC, USA). Descriptive
statistics (e.g., frequency, percentages, means) were used
to summarize demographic characteristics, diagnosis,
symptom ratings, and satisfaction ratings. Paired t tests
were used to compare the baseline scores to the first visit
postacupuncture scores and to the final visit post-
acupuncture scores. Ratings of 1 indicated the absence of a
symptom, whereas ratings above 1 indicated the presence
of a symptom. Significance was defined as p < 0.05. Clini-
cally meaningful differences between the baseline and
post-scores were defined as a change in rating score of at
least 2 points [27].
3. Results
Cancer patients (N Z 90) were primarily non-Hispanic
(89%), white (82%), and female (69%) with a mean age of
52 years (range, 20e74 years). The top four cancer di-
agnoses were breast cancer (41%), colorectal cancer (12%),
hematological cancer (10%), and other gastrointestinal
cancers (8%). Two cancer patients had concurrent primary
cancers of the breast and another site. The modal number
of visits was one session (N Z 25, 28%), and 65 (72%) pa-
tients received at least two acupuncture sessions (Fig. 1).
The maximum number of sessions received by a single pa-
tient was 23. The length of the session was 60 minutes in
93% of first visits and 30 minutes in 89% of final visits.
At baseline, most patients reported the presence (i.e., a
rating > 1) of pain (83%), fatigue (84%), anxiety (63%),
130 L.M.A. Thompson et al.overall emotional distress (70%), overall physical distress
(73%), and worse quality of life (76%), and, except for
anxiety, more than one-half of patients reported a symp-
tom rating of at least 4 (Table 1). Nausea was the least
prevalent symptom (21%), and few (10%) patients rated the
intensity of nausea as  4. Symptoms with a mean rating of
at least 4 at baseline were fatigue (mean score, 4.47), pain
(mean score, 4.40), overall emotional distress (mean score,
4.17), overall physical distress (mean score, 4.34), and
overall quality of life (mean score, 4.42). All mean score
symptom ratings were below 3.5 post-first visit and post-
last visit. Paired t-tests revealed significant (p < .05) re-
ductions in symptom intensity post-first visit for all symp-
toms (Table 2). With the exception of nausea, similar
results were found when comparing baseline scores to the
post-last visit acupuncture scores for patients who
completed at least two acupuncture sessions (Table 3).
To examine whether changes in ratings represented
clinically meaningful differences, a decrease of  2 points
in the rating score was defined as an improvement, whereas
an increase of  2 points in the rating score was defined as
worse functioning. Rates of improvement of  2 points
immediately after the first session exceeded 30% for all
symptoms, except for nausea, which had a 7% rate of
improvement (Fig. 2). The rate of improvement of  2
points after the last session similarly exceeded 41% for all
symptoms, except for nausea, which had a 10% rate of
improvement (Fig. 3). A small subset (0e8%) of patients
reported worse pain, fatigue, anxiety, overall emotional
distress, overall physical distress, and worse quality of life
post-first visit and post-last visit.Table 2 Mean symptom ratings from baseline to the post-first
Symptom Baseline Post-fi
Pain (N Z 87) 4.40  2.50 3.01
Nausea (N Z 85) 1.56  1.32 1.21
Fatigue (N Z 87) 4.47  2.54 3.17
Anxiety (N Z 85) 3.68  2.79 2.42
Physical distress (N Z 77) 4.34  2.76 2.74
Emotional distress (N Z 81) 4.17  2.87 2.69
Quality of life (N Z 79) 4.42  2.49 3.24
Data are presented as mean  SD.
*Significance is at p < 0.05, based on paired t-tests.
Table 3 Mean symptom ratings of patients who completed at l
Symptom Baseline Post-l
Pain (N Z 64) 4.21  2.50 2.70
Nausea (N Z 58) 1.60  1.30 1.34
Fatigue (N Z 64) 4.42  2.68 2.39
Anxiety (N Z 61) 3.51  2.67 1.89
Physical distress (N Z 58) 4.34  2.87 2.22
Emotional distress (N Z 59) 4.10  2.91 2.14
Quality of life (N Z 59) 4.12  2.52 3.14
Data are presented as mean  SD.
*Significance is at p < 0.05, based on paired t-tests.Most (92%) patients were satisfied or very satisfied with
the first acupuncture session. All (100%) patients rated the
quality of care from their provider as good to excellent and
94% were somewhat or very likely to recommend
acupuncture to other patients. The results for the last visit
were similar, with 95% of patients satisfied or very satisfied
with the acupuncture session, 99% of patients satisfied with
the quality of care, and 96% of patients likely to recom-
mend acupuncture.
4. Discussion
In this retrospective study of clinical care data, we exam-
ined patient-reported outcomes and satisfaction with
acupuncture services provided by a physicianeacupunctu-
rist. Well-designed RCTs are needed to demonstrate the
treatment’s efficacy, although we believed that it was
necessary to assess the effectiveness of acupuncture ser-
vices that were already being provided to patients as
adjunct treatment to standard cancer care. Patients
seeking acupuncture services at our institution most
commonly presented with individual symptoms of fatigue,
pain, and anxiety. Nearly 60% of patients rated the severity
of their fatigue and pain as moderate or greater. Ratings of
physical and emotional distress and poor quality of life
were also notably high. These high prevalence rates suggest
that some cancer patients are seeking additional tech-
niques for managing these symptoms. Nausea was the least
common symptom reported. This could be because patients
experiencing nausea were most likely receiving chemo-
therapy and may not have been referred because of theacupuncture session.
rst visit Difference from baseline p*
 1.97 1.39  1.69 < 0.0001
 .69 .35  1.02 0.002
 2.14 1.30  1.81 < 0.0001
 1.94 1.26  1.88 < 0.0001
 2.12 1.60  2.48 < 0.0001
 2.17 1.48  2.42 < 0.0001
 2.51 1.18  2.28 < 0.0001
east two acupuncture sessions.
ast visit Difference from baseline p*
 1.84 1.52  2.45 < 0.0001
 .87 .26  1.26 0.1248
 1.72 2.03  2.57 < 0.0001
 1.43 1.62  2.33 < 0.0001
 1.61 2.12  2.66 < 0.0001
 1.84 1.97  2.50 < 0.0001
 2.27 0.98  2.15 0.0009
Figure 2 The percentage of patients reporting a two-point or greater change in symptom ratings from baseline to post-first visit
(i.e., clinically significant changes).
Acupuncture for Symptom Control in Cancer 131risks associated with providing acupuncture in potentially
neutropenic patients. It is also possible that patients
experiencing nausea did not choose to receive acupuncture
to help manage this symptom.
The presence of multiple concurrent symptoms in our
sample may represent a symptom cluster such as the fa-
tigue/pain/drowsiness/poor sense of well-being cluster
identified by Chow and colleagues [28] in a study of 518
cancer patients with bone metastases. Acupuncture may
provide a mechanism to treat multiple symptoms with one
modality, thereby limiting the risk of polypharmacy, which
can occur when treating each symptom individually [29].
A primary finding of the study was that, after the last
acupuncture session, acupuncture had a beneficial effect
on all symptoms, with the exception of nausea. Patients
experienced immediate relief of symptoms after the first
session and sustained the relief, as measured by the ratings
scales completed after the last acupuncture session. Other
observational studies of acupuncture have also shownFigure 3 The percentage of patients reporting a two-point or gre
(i.e., clinically significant changes).similar benefits of acupuncture on cancer symptom man-
agement [25,26,30e32]. These results are promising, but
the possibility of a placebo effect must be considered.
Randomized controlled trials that compare true acupunc-
ture with sham acupuncture in cancer samples [7,33] and
noncancer samples [34] showed similar positive results for
both groups. Patients willing to receive and pay for
acupuncture services may be a unique, self-selected group
with higher expectations for a positive result. For example,
Mao and colleagues [35] found that breast cancer patients
who were willing to enroll in an acupuncture trial had
higher response expectancies, compared to patients who
declined participation. Additional research suggests that
expectancy may be a moderator variable. A recent study by
Bauml and colleagues [36] found that more than one-half of
women who received electroacupuncture or sham
acupuncture experienced a reduction in aromatase
inhibitor-related joint pain. Baseline response expectancy
predicted whether women in the sham acupuncture groupater change in symptom ratings from baseline to post-last visit
132 L.M.A. Thompson et al.were responders, but it did not predict whether women
were responders or nonresponders when they were in the
electroacupuncture group.
Another important finding is that the reduction in pa-
tient symptoms represented clinically meaningful differ-
ences [27] for at least one-third of the sample.
Furthermore, a subset of patients reported worse symp-
toms after receiving acupuncture. The lack of information
on adverse events experienced by the patients is a limita-
tion of the study. Despite this deficit, the results of the
study raise the question of which factors may predict a
negative response to acupuncture. Most patients in our
study were non-Hispanic or white females, which may limit
the generalizability of the results to other populations.
However, this finding is consistent with other studies of
acupuncture [30,32] and with studies examining the use of
complementary and alternative medicine such as
acupuncture in cancer populations [37,38].
The clinical symptom rating scales used in this study
were designed for clinical purposes and were not validated.
A limited number of items were assessed to keep the
questionnaire length brief and minimize patient response
burden. However, patients may have experienced other
symptoms such as insomnia or sensory neuropathy, which
would have been important to assess. In the United States,
the National Cancer Institute Symptom Management and
Health-Related Quality of Life Steering Committee has
suggested a core set of 12 cancer symptoms that should be
assessed when conducting patient-reported outcome
research [39]. These include anorexia/appetite loss, dys-
pnea, fatigue, pain, nausea, sensory neuropathy, con-
stipation, diarrhea, anxiety, depression, insomnia, and
cognitive problems.
There are a number of other limitations to this study.
This was a retrospective study of clinical data collected via
paper forms; therefore, limited information was available.
It is possible that other clinical factors (stage, treatment,
time since diagnosis, medication usage) could have influ-
enced the treatment response. Ratings were collected by
the acupuncture physician, which possibly influenced pa-
tients to respond favorably. The sample size was small and
inconsistent across measured variables because of missing
data. However, this represents actual clinical practice as
patients often do not complete requested self-report forms
and busy practitioners may not have the time to verify the
completion of forms. In addition, one-third of patients
received only one session. It is possible that these could be
patients who did not perceive a benefit from their first
acupuncture visit. However, a comparison of patients who
completed only one session with patients who completed
two or more sessions revealed no significant differences
between the two groups in the symptoms ratings or the
satisfaction ratings. Although the sample size of this study
is small, our sample size is larger or equivalent to other
pragmatic studies of acupuncture [30,32].
In conclusion, acupuncture may be useful as an adjunct
treatment for cancer symptom management. High-quality
RCTs are still needed to understand the mechanisms of
action, dosing, and effectiveness [5]; however, patients
may benefit from these primarily safe, low-cost services.
Because a subset of patients did not respond, it would beimportant to also study which group of patients would
receive the most benefit from these services.Disclosure statement
The authors declare that they have no conflicts of interest
and no financial interests related to the material of this
manuscript.References
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